- Report
- May 2022
- 100 Pages
Europe
From €1346EUR$1,500USD£1,158GBP
- Report
- May 2022
- 82 Pages
North America
From €1346EUR$1,500USD£1,158GBP
- Report
- May 2022
- 296 Pages
Global
From €3230EUR$3,600USD£2,780GBP
- Report
- January 2021
- 201 Pages
Global
From €3230EUR$3,600USD£2,780GBP
- Report
- February 2024
- 90 Pages
Global
From €3500EUR$4,178USD£3,118GBP
- Report
- April 2024
- 140 Pages
Global
From €4441EUR$4,949USD£3,822GBP
- Report
- September 2023
- 160 Pages
Global
From €3229EUR$3,599USD£2,779GBP
- Report
- May 2023
- 147 Pages
Global
From €4441EUR$4,949USD£3,822GBP
- Report
- August 2023
- 51 Pages
United Kingdom
From €377EUR$420USD£324GBP
€538EUR$600USD£463GBP
- Report
- August 2023
- 51 Pages
Australia
From €377EUR$420USD£324GBP
€538EUR$600USD£463GBP
- Report
- August 2023
- 51 Pages
Japan
From €377EUR$420USD£324GBP
€538EUR$600USD£463GBP
- Report
- August 2023
- 51 Pages
United States
From €377EUR$420USD£324GBP
€538EUR$600USD£463GBP
- Report
- August 2023
- 51 Pages
Argentina
From €377EUR$420USD£324GBP
€538EUR$600USD£463GBP
- Report
- August 2023
- 51 Pages
Brazil
From €377EUR$420USD£324GBP
€538EUR$600USD£463GBP
- Report
- August 2023
- 51 Pages
Mexico
From €377EUR$420USD£324GBP
€538EUR$600USD£463GBP
- Report
- August 2023
- 51 Pages
Canada
From €377EUR$420USD£324GBP
€538EUR$600USD£463GBP
- Report
- August 2023
- 51 Pages
China
From €377EUR$420USD£324GBP
€538EUR$600USD£463GBP
- Report
- August 2023
- 51 Pages
Germany
From €377EUR$420USD£324GBP
€538EUR$600USD£463GBP
- Report
- August 2023
- 51 Pages
France
From €377EUR$420USD£324GBP
€538EUR$600USD£463GBP
- Report
- August 2023
- 51 Pages
Turkey
From €377EUR$420USD£324GBP
€538EUR$600USD£463GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more